Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Preveceutical Medical Inc C.PREV

Alternate Symbol(s):  PRVCF

PreveCeutical Medical Inc. is a Canada-based health sciences company. The Company’s principal business activity is the development of options for preventive and curative therapies utilizing organic and nature identical products. The Company’s pipeline includes Cannabinoid Sol-Gel, Non-Addictive Analgesic, BSV Peptide Program and Dual Gene Therapy. Its Cannabinoid Sol-Gel is cannabinoid-based... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (CSE:PREV)

PREVECEUTICAL INITIATES PREPARATION OF PROOF-OF-CONCEPT PRECLINICAL STUDY FOR ITS DIABETES & OBESITY DUAL GENE THERAPY PROGRAM

PR Newswire December 4, 2023

PreveCeutical & Endosane Announces Innovative Preclinical Approaches to Assess Brain Availability of CBD And Pharmacologically Relevant Doses Following Intranasal CBD Application

PR Newswire September 18, 2023

PreveCeutical Showcases Dynamic Evolution in AI Strategy

PR Newswire September 12, 2023

PreveCeutical Engages New to the Street for Production & Broadcasting Services

PR Newswire August 31, 2023

PreveCeutical Files Cyclic Peptides And Uses Thereof in the EU and Australia

PR Newswire July 24, 2023

PreveCeutical Files Two Family Patents of Sol-Gel Cannabinoid Formulation and Antiviral Use & Cyclic Peptides and Uses Thereof

Newsfile June 28, 2023

PreveCeutical Medical - Sol-Gel and Uses thereof Patent Update

Newsfile May 30, 2023

PreveCeutical Medical Launches Clinical Artificial Intelligence Division

Newsfile April 24, 2023

PreveCeutical Medical Announces Live Interactive Q&A Video Conference

Newsfile April 20, 2023
View More News ››

Opinion & Analysis (CSE:PREV)

Buzz on the Bullboards: Show Me The Money!

Stockhouse Editorial November 9, 2018

PreveCeutical making headway with cannabinoid delivery system

Proactive Investors July 20, 2018

Multifaceted biotech company poised to begin trading on Canadian Securities Exchange

The Life Sciences Report July 13, 2017

Cannabis, scorpions, and synthesizing better drugs

Stockhouse Editorial May 12, 2017
View More Opinion ››

Bullboard Posts (CSE:PREV)

Still nothing happened

Volume was up the whole week, but sp still stay in 0.02
den1731 - March 14, 2024

Shaping up to be quite the year of M&A activity

[url=https://https://www.cnbc.com/2024/01/05/cramer-names-biopharma-companies-as-industry-mergers-start-to-accrue.html]news on M&A...
Walter333 - January 8, 2024

RE:Something happening!

Wrong board!  oopsed!
geodcan - December 31, 2023

Something happening!

OTCPK:BMKDF | Insider Transactions | BioMark Diagnostics Inc (stockhouse.com)
geodcan - December 31, 2023

Tic tock tic tock

https://www.cnbc.com/2023/12/13/fed-interest-rate-decision-december-2023.html
Walter333 - December 13, 2023

Potential upcoming catalysts

Endosane payment(s) related to sol gel. Secure funding Partnership announcement Commencement of trials
Walter333 - December 13, 2023
View more Bullboard ››

Ucore Rare Metals Inc.

Ucore Rare Metals Inc.

Ucore is focused on rare and critical-metal resources, extraction, beneficiation, and separation technologies with the ...
View More »